CD4 and myeloid sarcoma: In RR/PPMS, Tregs (CD4+CD25+CD127−) levels were stable as compared to controls, although resting Tregs (CD45RA+CD25dim) were reduced, while activated Tregs (CD45RA−CD25bright) were increased in active MS (207, 208).